Protective effect of minocycline on cell apoptotic model of Parkinson's disease
Xuebin Cao
Abstract
Xuebin Cao
Abstract
Objective To explore the protective effect mechanism of minocycline (MC) on cell apoptotic model of Parkinson's disease induced by 1-methyl-4-phenylpyridinium (MPP+ ).Methods Different concentrations of MPP+ (10, 50, 250, 500 μmol/L) were added into the culture of PC12 cells. The most appropriate concentration of MPP+ (MPP+ group) was selected to establish apoptotic model of dopaminergic neurons. For selecting the most a-ppropriate concentration MC (MC+MPP+ group) of protective effect, MTT was used to assay the viability of model of dopaminergic neurons pretreated by different concentrations MC (0, 10, 50, 100, 200 μmol/L). The cell apoptosis, apoptosis ratio and caspase-3 mRNA expression of MPP+ group and MC+MPP+ group were assayed by electrophoresis method, flow cytometry and RT-PCR, and compared with control group.Results (1) At concentration of 10 μmol/L of MPP+, cell parkinsonism model of apoptosis was established. The cell viability of apoptotic model of dopaminergic neurons was the highest when pretreated by 100 μmol/L of MC ( P0.05). (2) The apoptosis ratio and caspase-3 mRNA expression of MC+MPP+ group were (22.83±2.10)% and 68.08±1.14,significantly lower than those of MPP+ group [( 45.89±2.28)% and 86.50±1.43](all P0.01), but were still significantly higher than those of control group [(11.05±1.02)% and 53.75±1.23](all P0.05).Conclusion MC might down-regulate mRNA expression of caspase-3 to alleviate PC12 cell apoptosis induced by MPP+ .
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the protective effect mechanism of minocycline (MC) on cell apoptotic model of Parkinson's disease induced by 1-methyl-4-phenylpyridinium (MPP+ ).Methods Different concentrations of MPP+ (10, 50, 250, 500 μmol/L) were added into the culture of PC12 cells. The most appropriate concentration of MPP+ (MPP+ group) was selected to establish apoptotic model of dopaminergic neurons. For selecting the most a-ppropriate concentration MC (MC+MPP+ group) of protective effect, MTT was used to assay the viability of model of dopaminergic neurons pretreated by different concentrations MC (0, 10, 50, 100, 200 μmol/L). The cell apoptosis, apoptosis ratio and caspase-3 mRNA expression of MPP+ group and MC+MPP+ group were assayed by electrophoresis method, flow cytometry and RT-PCR, and compared with control group.Results (1) At concentration of 10 μmol/L of MPP+, cell parkinsonism model of apoptosis was established. The cell viability of apoptotic model of dopaminergic neurons was the highest when pretreated by 100 μmol/L of MC ( P0.05). (2) The apoptosis ratio and caspase-3 mRNA expression of MC+MPP+ group were (22.83±2.10)% and 68.08±1.14,significantly lower than those of MPP+ group [( 45.89±2.28)% and 86.50±1.43](all P0.01), but were still significantly higher than those of control group [(11.05±1.02)% and 53.75±1.23](all P0.05).Conclusion MC might down-regulate mRNA expression of caspase-3 to alleviate PC12 cell apoptosis induced by MPP+ .
Key concepts: Apoptosis, Viability assay, MTT assay, Dopaminergic, Flow cytometry, Molecular biology, Chemistry, Cell